ritanserin has been researched along with Anxiety Neuroses in 5 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ritanserin, (20 mg daily) and lorazepam (5 mg daily) were administered to 24 patients suffering from generalized anxiety disorders (DSM III), in a double-blind fashion for six weeks." | 9.06 | Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam. ( Bressa, GM; Gregori, S; Marini, S, 1987) |
| "The selective serotonin reuptake inhibitor (SSRI) fluvoxamine has been used in an attempt to understand whether there is a biological distinction among anxiety disorders." | 7.69 | Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. ( De Leeuw, AS; den Boer, JA; van Vliet, IM; Westenberg, HG, 1995) |
| " Ritanserin, (20 mg daily) and lorazepam (5 mg daily) were administered to 24 patients suffering from generalized anxiety disorders (DSM III), in a double-blind fashion for six weeks." | 5.06 | Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam. ( Bressa, GM; Gregori, S; Marini, S, 1987) |
| "The selective serotonin reuptake inhibitor (SSRI) fluvoxamine has been used in an attempt to understand whether there is a biological distinction among anxiety disorders." | 3.69 | Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. ( De Leeuw, AS; den Boer, JA; van Vliet, IM; Westenberg, HG, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| den Boer, JA | 1 |
| Westenberg, HG | 1 |
| De Leeuw, AS | 1 |
| van Vliet, IM | 1 |
| Lapierre, YD | 1 |
| da Roza Davis, JM | 1 |
| Sharpley, AL | 1 |
| Cowen, PJ | 1 |
| Bressa, GM | 1 |
| Marini, S | 1 |
| Gregori, S | 1 |
| Ceulemans, DL | 1 |
| Hoppenbrouwers, ML | 1 |
| Gelders, YG | 1 |
| Reyntjens, AJ | 1 |
1 review available for ritanserin and Anxiety Neuroses
| Article | Year |
|---|---|
Pharmacological therapy of dysthymia.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzamides; Benzodiazepines; Depressive Disorde | 1994 |
3 trials available for ritanserin and Anxiety Neuroses
| Article | Year |
|---|---|
Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.
Topics: Adult; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status | 1992 |
Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Double-Blind Method; Female; Humans; Lorazepam; Male; Pi | 1987 |
The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lorazepam; | 1985 |
1 other study available for ritanserin and Anxiety Neuroses
| Article | Year |
|---|---|
Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
Topics: Anxiety Disorders; Fluvoxamine; Humans; Maprotiline; Obsessive-Compulsive Disorder; Panic; Receptors | 1995 |